Sessão de Relato de Caso


Código

RC037

Área Técnica

Doenças Sistêmicas

Instituição onde foi realizado o trabalho

  • Principal: Hospital Oftalmológico Visão Laser

Autores

  • JOAO CARLOS GONCALVES CRUZ (Interesse Comercial: NÃO)
  • CELSO BUSNELO MORENO (Interesse Comercial: NÃO)
  • MARCELLO NOVOA COLOMBO BARBOZA (Interesse Comercial: NÃO)

Título

ANTERIOR SCLERITIS AS AN OCULAR MANIFESTATION OF CHIKUNGUNYA INFECTION

Objetivo

Chikungunya is a matter of grave concern in Brazil. This case report describes a rare ocular manifestation in a patient with chikungunya.

Relato do Caso

A 49-year old male, systems analyst, presented with complaints of pain and hyperemia in both eyes over the preceding seven days, increasing at movement and touch. One month previously, the patient had been diagnosed with chikungunya, and was being treated and followed up by a rheumatologist. Biomicroscopy of both eyes revealed bulbar conjunctival hyperemia 3+/4+ with 360 degrees of ciliary injection, and no other abnormalities. Fundoscopy detected no abnormalities in either eye. The patient was submitted to a phenylephrine test (1%), with the response being negative after 10 minutes. The patient was prescribed 1 drop of loteprednol etabonate every four hours, tapering every three days, and nimesulide 100 mg every 12 hours for 7 days. One week later, however, scleritis was worse and the medial sclera was elevated, particularly in the right eye, revealed by optical coherence tomography. Intraocular pressure remained normal, and hyperemia increased to 4+/4+ in the right eye. Supplementary tests revealed positive serology for chikungunya IgG and IgM antibodies and other etiologies were ruled out. Treatment was then changed to oral prednisone 60 mg/day, tapering every three days. The patient was pain-free three days later with all signs and symptoms having disappeared within five days.

Conclusão

Ocular abnormalities resulting from chikungunya virus infection require careful monitoring even after the acute phase of chikungunya infection has passed. The fact that patients usually stop being followed-up after they have been symptomless for some time delays diagnosis and the appropriate treatment of ocular manifestations. Consequently, chikungunya should be included in the differential diagnosis of ocular pathologies wherever the infection is endemic or epidemic.

Promotor

Realização - CBO

Organização

Organizadora

Transporte Terrestre

Transporte Terrestre

Agência de Turismo

Agência Oficial de Turismo

Agência Web

Sistema de Gerenciamento desenvolvido por Inteligência Web

Patrocinador Platina

Genom
Johnson & Johnson

Patrocinador Ouro

Allergan

Patrocinador Prata

Alcon
Latinofarma

Patrocinador Bronze

Essilor
Ofta
Zeiss

Patrocínio

Roche

66º Congresso Brasileiro de Oftalmologia

07 a 10 de setembro de 2022 | Curitiba/PR

Política de privacidade